bioRxiv Science⌕ Search

bioRxiv · 10.1101/2023.09.11.557115

A computational model of the spatiotemporal adaptation of tumor cells metabolism in a growing spheroid

Abstract

The Warburg effect, commonly depicted as an inherent metabolic trait of cancer in literature, is under intensive investigation to comprehend its origins. However, while the prolonged presence of excessive lactic acid production in tumors has been noted, it merely constitutes a fraction of the potential metabolic states cancer cells can adopt. This study aimed to elucidate the emergence of spatiotemporal diversity in tumor energy metabolism by expanding an existing model based on experimental facts. The resulting hybrid model integrates discrete formulations for individual cells and their processes, along with continuous elements for metabolism and the diffusion of crucial environmental substrates like oxygen, glucose, lactate, and the often underestimated acidity. This model enables simulation of a tumor spheroid, a standard experimental model, composed of numerous cells which can have distinct traits. By subjecting the spheroid to alterations of the environment such as cyclic hypoxia, acid shocks, or glucose deprivation, novel insights into metabolic regulation were obtained. The findings underscore the significance of the pyruvate-lactate interaction in governing tumor metabolic routes. Integrating aciditys impact into the model, revealed its pivotal role in energy pathway regulation. Consequently, the conventional portrayal of a respiration/fermentation dichotomy proves inaccurate, as cells continuously and spatially adjust the ratio of these energy production modes, in contrast to abrupt, irreversible switches. Moreover, a cooperative cellular behavior akin to the reverse Warburg effect has emerged. This implies that the Warburg effect is not universally inherent to tumor metabolism, but a contextual, transient metabolic expression. Ultimately, the dynamic cellular-environment metabolic landscape influences cells survival under external conditions, with epigenetic regulations shaping their mobility potential within this landscape. While genetic mutations within tumor cells are undoubtedly present, this study shows they are not invariably essential for extreme metabolic modes or pathological characteristics to arise. Consequently, this research paves the way for innovative perspectives on metabolism, guiding tailored therapeutic strategies that consider not just patient-specific tissue attributes but also treat tumors as intricate ecosystems beyond their genetic diversity. Author SummaryFor years, scientists have been intrigued by the peculiar energy consumption patterns of cancer cells, such as the Warburg effect characterized by excessive lactic acid production. This study aimed to decipher the underlying reasons for the varying energy behaviors observed in different parts of tumors. Using a computational model, we simulated the collaborative dynamics of cells within tumors. The results revealed compelling insights. Two molecules, pyruvate and lactate, were identified as influential players in shaping energy utilization. Remarkably, the surrounding acidity was also found to exert a significant impact. Interestingly, tumor cells display a certain flexibility in their energy production strategies, adjusting according to prevailing conditions to maintain their survival and adaptability. Interestingly, cellular cooperation challenges the Warburg effect as an omnipresent phenomenon and reveals a transient nature. Our study underscores the significance of environmental influences, shedding light on the interplay between genetic modifications and the tumor environment in shaping cellular behavior. These findings hold promise for transforming cancer comprehension and devising treatments that tailor to both patients and the distinctive characteristics of their tumors.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Stephanou, A., Jacquet, P.. 2023-09-14. A computational model of the spatiotemporal adaptation of tumor cells metabolism in a growing spheroid. https://doi.org/10.1101/2023.09.11.557115

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

m6A-Driven Intratumoral Cholesterol Biosynthesis Fuels Castration-Resistant Prostate Cancer Progression

Both nuclear pore complexes (NPCs) and RNA N6-methyladenosine (m6A) machinery are indispensable for proper cellular function. Although their collaborative roles in the nuclear export of messenger RNAs (mRNAs) have been reported, it remains ambiguous whether and how this collaboration may contribute to cancer progression. Here we identify a functional cooperation between NPCs and m6A signaling that promotes the development of castration-resistant prostate cancer (CRPC). We showed that nuclear export of m6A-modified mRNAs, mediated by the interaction between RNA methyltransferase METTL3 and the nucleoporin NUP93, is functionally coupled to cholesterol biosynthesis. Given that cholesterol-fueled intratumoral androgen production is one of the mechanisms driving CRPC, we demonstrated that overexpression of the wild-type METTL3 or NUP93, but neither the enzymatically dead METTL3 nor the mutant NUP93 that loses METTL3-interacting capability, elevates intracellular levels of androgens, activates AR signaling under castrate condition, and promotes androgen-independent growth of prostate cancer cells both in vitro and in vivo. Importantly, pharmacological inhibition of METTL3 or targeted demethylation on mRNAs encoding key cholesterol biosynthesis enzymes effectively suppressed CRPC malignancy. Together, these findings uncover a therapeutically targetable m6A-METTL3-NUP93 axis that links nuclear mRNA export and metabolic reprogramming to fuel CRPC progression, providing a conceptually new strategy for the treatment of this lethal disease.

cancer biology↗

ST6Gal2 promotes α2,6-sialylation and aggressive phenotypes in neuroblastoma cells

Neuroblastoma is the most common extracranial solid tumor of childhood. Its clinical behavior ranges from spontaneous regression to lethal, treatment-refractory disease. Aberrant 2,6-sialylation contributes to aggressive phenotypes in many cancers, but the role of ST6Gal2, a neural-enriched 2,6-sialyltransferase, in neuroblastoma is largely unexplored. Here, we examine the clinical and functional significance of ST6Gal2 in neuroblastoma. In two independent public cohorts (SEQC, n=498; Kocak, n=649), high ST6GAL2 expression was associated with significantly worse overall and event-free survival. In the SEQC cohort, ST6GAL2 expression was higher in high-risk and MYCN-amplified tumors, varied across International Neuroblastoma Staging System stages, and correlated positively with a mesenchymal transcriptional signature (Spearman {rho}=0.181). The mesenchymal correlation was reproduced in the Kocak cohort ({rho}=0.204). Stable shRNA-mediated knockdown of ST6GAL2 in SK-N-AS and SK-N-BE(2) cells reduced proliferation and viability, impaired wound closure, and decreased migration and invasion. In preliminary experiments in SK-N-AS cells, ST6GAL2 knockdown reduced binding of Sambucus nigra agglutinin, consistent with a role for ST6Gal2 in 2,6-sialylation. Together, these findings link ST6Gal2 expression to aggressive clinical and transcriptional features and pro-tumorigenic phenotypes in neuroblastoma and nominate ST6Gal2-mediated sialylation as a candidate pathway for mechanistic study.

cancer biology↗

Unsupervised transcriptomic analysis of paired pre- and post-treatment specimens reveals divergent chemoimmunomodulatory induction trajectories in breast cancer

The immunomodulatory effects of chemotherapy (chemoimmunomodulation; CIM) are clinically consequential and heterogeneous, yet no systematic framework exists for classifying the immunomodulatory trajectory a tumor follows in response to treatment (CIM trajectory). Here, we present the CIM Induction Classifier (CIMIC), an unsupervised clustering pipeline leveraging delta gene expression across 3,189 CIM-related genes to classify specimens chemoimmunomodulatory trajectory. Applied to two pre- and post-chemotherapy breast cancer (BC) datasets (NKI/SMC, N = 36; NEO, N = 19) and nine epirubicin-perturbed triple-negative BC (TNBC) cell lines, CIMIC identified two divergent CIM trajectories: a functional CIM (Fun-CIM) trajectory, broadly conserved across tumors and cell lines and characterized by induction of inflammatory cell death, antigen presentation, viral mimicry, and adaptive immune activation programs, and a dysfunctional CIM (Dys-CIM) trajectory, characterized by induction of proteostatic and metabolic stress-adaptation programs, reduced immune cell abundances and cytotoxic activity, and enrichment of aggressive BC subtypes. Using survival and longitudinal transcriptomic data in NKI/SMC (N = 20), treatment-induced increases in Fun-CIM-associated genes and ssGSEA scores were associated with reduced recurrence, whereas Dys-CIM-associated genes and scores were associated with increased recurrence. In multivariable analyses within independent chemotherapy-treated BC cohorts (METABRIC, N = 412; SCAN-B, N = 2,462), higher baseline Fun-CIM ssGSEA scores were associated with better outcomes, whereas higher baseline Dys-CIM ssGSEA scores were associated with worse outcomes. These findings establish CIM as a dynamic, trajectory-level process and position CIMIC as a framework for defining CIM trajectories and supporting future efforts to identify predictors, mechanisms, and therapeutic strategies that maximize beneficial CIM.

cancer biology↗